HUHideaki Uchida

Hideaki Uchida

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hideaki Uchida has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of ion channels in immune regulation of psoriasis

    by Hideaki Uchida, Xuesong Wu, Yan Zhou, Jie Zheng, Heike Wulff, Samuel T Hwang


  • Serum interleukin‐10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

    by Shoya Suzuki, Masahiro Kamata, Hideaki Uchida, Teruo Shimizu, Yoshiki Okada, Makoto Ito, Ayu Watanabe, Itsumi Mizukawa, Shota Egawa, Chika Chijiwa, et al.

    Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease with a linear deposit of autoantibodies at the epidermal basement membrane zone. It was reported that diabetes patients who took a dipeptidyl peptidase‐4 inhibitor (DPP4i), an oral antidiabetic drug, had an increased incidence of BP. However, data on DPP4i‐related BP are limited. In our study, we measured serum levels of various cytokines using LEGENDplex and assessed correlations of these serum levels with clinical severity and laboratory data. Serum samples obtained from BP patients who visited our hospital from June 2016 to February 2023 were collected in this study. Patients' background, characteristics, and clinical data were retrospectively collected from their charts. Serum samples from 27 patients with DPP4i‐unrelated BP, 17 patients with DPP4i‐related BP, and 13 healthy controls were analyzed. Patients with DPP4i‐related BP had lower score of Bullous Pemphigoid Disease Area Index (BPDAI)‐erythema/urticaria, lower number of circulating eosinophils, and lower titer of anti‐BP180 antibody than patients with DPP4i‐unrelated BP. The serum interleukin (IL)‐6 level was significantly higher in patients with DPP4i‐related BP than in healthy controls ( P = 0.0037). The serum IL‐10 level was significantly higher in patients with DPP4i‐related BP than in patients with DPP4i‐unrelated BP and in healthy controls ( P = 0.0006, P = 0.0448), and was positively correlated with the BPDAI‐blister/erosions score ( r = 0.757, P = 0.001), BPDAI‐erythema/urticaria score ( r = 0.616, P = 0.013), and BPDAI‐total score ( r = 0.833, P < 0.001) in patients with DPP4i‐related BP. In conclusion, patients with DPP4i‐related BP had increased serum levels of IL‐6 and IL‐10 compared with healthy controls and positive correlations between the serum IL‐10 level and BPDAI scores reflecting clinical severity, indicating that the serum IL‐10 level is a potential objective biomarker of disease severity in patients with DPP4i‐related BP.


  • Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin‐17 inhibitors in a patient with generalized pustular psoriasis: A case report

    by Shoya Suzuki, Masahiro Kamata, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Chika Chijiwa, Saori Azuma, Kotaro Hayashi, Kazumitsu Sugiura, Yayoi Tada


  • Interleukin‐23 inhibitors decrease Fibrosis‐4 index in psoriasis patients with elevated Fibrosis‐4 index but not interleukin‐17 inhibitors

    by Ryosuke Takeshima, Masahiro Kamata, Shoya Suzuki, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Chika Chijiwa, Yoshiki Okada, Saori Azuma, Mayumi Nagata, et al.

    Recent studies indicate that hepatic diseases are associated with psoriasis. Non‐invasive tests, including the Fibrosis‐4 (FIB‐4) index, which can confidently rule out the presence of advanced fibrosis, are currently receiving attention. However, data on the FIB‐4 index in psoriasis patients and the effects of biologics on the FIB‐4 index are limited. We investigated the relationships between the FIB‐4 index and demographic or clinical characteristics as well as the effects of biologics on the FIB‐4 index in psoriasis patients. Psoriasis patients aged 36–64 years, whose treatment was initiated with interleukin (IL)‐17 inhibitors or IL‐23 inhibitors for psoriasis from May 2015 to December 2022, were consecutively included. Data were collected retrospectively from the patients' charts. A total of 171 psoriasis patients were included in this study. Thirty‐four, 43, 21, 32, and 41 psoriasis patients were treated with secukinumab, ixekizumab, brodalumab, guselkumab, or risankizumab, respectively. In biologics‐naïve patients, a significant but weak positive correlation was observed between the FIB‐4 index and age (r = 0.3246, p = 0.0018). There was no significant correlation between the FIB‐4 index and other demographic or clinical characteristics. Regarding the effects of biologics on the FIB‐4 index, no significant change was observed in psoriasis patients treated with any biologics. However, in psoriasis patients with a baseline FIB‐4 index of >1.3, patients treated with guselkumab and those treated with either IL‐23 inhibitor showed significantly decreased FIB‐4 index scores 6 months after initiating the biologics (p = 0.0323, p = 0.0212). In contrast, no change was observed in FIB‐4 index scores in patients treated with IL‐17 inhibitors. In conclusion, our study revealed that the FIB‐4 index was correlated with age in psoriasis patients. Furthermore, IL‐23 inhibitors (but not IL‐17 inhibitors) decreased the FIB‐4 index score at 6 months in psoriasis patients with elevated FIB‐4 index scores at baseline. Further studies are needed to clarify whether IL‐23 inhibitors improve liver fibrosis physiologically and functionally.


  • 308‐nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single‐center real‐world experience of treatment for palmoplantar pustulosis

    by Yoshiko Niimura, Masahiro Kamata, Takeko Ishikawa, Mayumi Nagata, Makoto Ito, Ayu Watanabe, Shota Egawa, Hideaki Uchida, Azusa Hiura, Saki Fukaya, et al.

    Palmoplantar pustulosis (PPP) is relatively rare and recognition of PPP is different in different countries. Therefore, real‐world data are limited. Local phototherapy for the palms and the soles is commonly used to treat PPP due to tolerable safety. However, data on the effectiveness of 308‐nm excimer light are limited. In our study, we retrospectively investigated the effectiveness of treatments for PPP, especially phototherapy (308‐nm excimer light), in our department. In addition, we examined whether smoking status and focal infection affected responsiveness to treatment of PPP. Patients who were diagnosed with PPP by board‐certified dermatologists and visited our hospital from April 2015 to August 2018 were analyzed in this study. We collected data on PPP area severity index (PPPASI) before treatment. We also collected data on PPPASI in May to August 2018 as “after treatment” from all patients. Patients who received any treatment for less than 3 months were excluded. Nineteen patients (16 women and three men) were analyzed in this study. In patients treated with phototherapy ( n = 12), PPPASI significantly decreased from a mean ± SD of 16.5 ± 10.3 to 4.5 ± 3.6 ( p = 0.004), whereas it did not in patients treated without phototherapy ( n = 7). Patients who quit smoking showed a significant decrease in PPPASI after treatment (16.8 ± 12.7 to 2.4 ± 2.9, p = 0.008). Regarding focal infection, in patients treated without phototherapy, the reduction rate of PPPASI was significantly lower in patients with focal infection than in those without focal infection (17.7 ± 21.5%, 71.1 ± 19.3%, p = 0.035), indicating that focal infection is associated with intractability. Meanwhile, in patients treated with phototherapy, PPPASI decreased regardless of the presence or absence of focal infection. In conclusion, our study demonstrated the effectiveness of local phototherapy consisting of 308‐nm excimer light, regardless of focal infection. Patients who quit smoking were responsive to any treatment, indicating the importance of smoking cessation.

  • Open Access

    Analyzing and modeling occupant behavior by inverse problems with smart meter data

    by Kazuki Nishizawa, Kazumasa Kishimoto, Hideaki Uchida, Yoshiyuki Shimoda, Yohei Yamaguchi, Kazuya Togawa

    A bottom-up energy demand estimation model considers changes in weather and equipment over time, so the model is useful for a quantitative evaluation of specific measures in the plan for global warming countermeasures. The model simulates the operation of equipment based on occupant behavior, equipment ownership, and so on. The input data is constrained by its survey methodology and frequency, and the accuracy of the input data leads to the difference between estimates and measured. We calibrated parameters related to occupant behavior and the operation of heating and cooling equipment by solving inverse problems with smart meter data. With the popularity of smart meters worldwide, the data of electricity consumption become available. However, in terms of the data capacity, management, and privacy protection, the resolution become rougher, so the development of methods to analyze such data have attracted attention. We utilize the very low-rate data of the order of 30 min by assuming the distribution of electricity consumption for each time and household type. The error measure was the Wasserstein distance between distribution of estimated and measured electricity consumption to reproduce with good accuracy not only the average electricity consumption of the target households, but the variation of the households.Amasyali et al. reviewed trends in the field of research that predicted data-driven energy demand estimation, most of which used machine learning methods such as support vector machine (SVM) and artificial neural network (ANN). Zhao et al. proposed the unsupervised learning method to decompose smart meter data into the electricity consumption of each equipment. In this study, we used a bottom-up residential energy end-use simulation model called TREES (Total Residential End-use Energy Simulation), in which occupant behavior is simulated by stochastic person-based activity model. This activity model probabilistically simulates the behavior of each resident, so the model can consider the variability in simulated activities among households and uses the Survey on time use and leisure activities, in which the data is collected from self-declaration of the activities on the limited surveyed days. Therefore, the data may deviate from the actual situation. We first calibrated the parameters related to occupant behavior in the intermediate period, and then calibrated the parameters related to the operation of heating and cooling equipment by Bayesian optimization to efficiently search for solutions. This allows us to clarify the trends in occupant behavior and the actual operation of heating and cooling equipment from electricity consumption.In the intermediate period, the sleep duration was shorter than that of the survey on time use and leisure activities, which is the input data of the activity model. However, the values were comparable to that of the highly reliable smartphone survey, indicating that the model reflects the actual occupant behavior. The error measure between distribution of estimated and measured electricity consumption was improved, while errors remained in the morning. This is because only parameters related to occupant behavior were calibrated, and it is necessary to add parameters, such as equipment performance, to the optimization target in the future. In the heating and cooling period, the distance between distribution of estimated and measured was greatly improved. The accuracy of TREES was improved, so we can quantitatively evaluate the effects of measures such as the Plan for Global Warming Countermeasures. Also, by interpreting the parameters, we can estimate the trend of occupant behavior from smart meter data, which is useful information for planning energy conservation measures in the residential sector.

  • Expression of interleukin‐36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene

    by Itsumi Mizukawa, Masahiro Kamata, Teruo Shimizu, Makoto Ito, Ayu Watanabe, Hideaki Uchida, Shota Egawa, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, et al.

    It has recently been revealed that mutation of the IL36RN gene contributes to the development of generalized pustular psoriasis (GPP). The IL36RN gene encodes interleukin (IL)‐36 receptor antagonist (IL‐36Ra), which has antagonistic roles against IL‐36α, ‐36β, and ‐36γ. Previously, sanger sequencing performed in 62 Chinese GPP patients to identify IL36RN mutations revealed a new variant, c.245C>T (p.Pro82Leu), in a single heterozygous state in a patient with adult‐onset GPP with psoriasis vulgaris. Since this p.Pro82Leu variant was not found in the psoriasis vulgaris or control groups in their study, they speculated that this variant might lead to exacerbated inflammatory responses. Meanwhile, Sorting Intolerant From Tolerant and PolyPhen‐2, pathogenicity prediction tools, predict this variant as tolerated and benign. To date, its pathogenicity is unknown. We experienced a patient with GPP harboring the p.Pro82Leu variant, and investigated mRNA and protein expressions of IL‐36Ra. Polymerase chain reaction conducted on hair follicle samples obtained from the scalp of the patient with GPP harboring the p.Pro82Leu using primers to detect mRNA of exons 2 and 5 in IL36RN demonstrated mRNA expression of IL36RN. Immunohistochemical staining revealed IL‐36Ra expression in the keratinocytes of the patient with GPP harboring the p.Pro82Leu as in those of a GPP patient without the mutation (positive control). Furthermore, quantitative analysis of the immunofluorescent staining by ImageJ revealed that the expression level of IL‐36Ra in the keratinocytes of the patient with GPP harboring p.Pro82Leu was higher than that in the healthy control and not lower than that in the GPP patients without the mutation. Our results indicate no aberrant splicing in this variant. In addition, according to the 1000 Genomes Project, this variant could be a founder mutation. Considering these factors together, this variant is unlikely to be associated with the development of GPP.


  • ESDR400 - 308-nm excimer lamp ameliorates MC-903 induced atopic dermatitis with a reduction of thymic stromal lymphopoietin mRNA levels.

    by Makoto Ito, Masahiro Kamata, Teruo Shimizu, Hideaki Uchida, Shota Egawa, Ryosuke Takeshima, Itsumi Mizukawa, Ayu Watanabe, Yayoi Tada

    Purpose Narrow band-ultraviolet B (NB-UVB) is efficacious for atopic dermatitis (AD). However, its detailed mechanism remains to be elucidated. T | POSTER

  • Simulation-based Evaluation of Dispatch Algorithm for Ride Share Service

    by Hideki Fujii, Yuki Yoshizuka, Hideaki Uchida, Shinobu Yoshimura

    Ride-sharing services are expected to solve or relax some traffic issues such as traffic jams, high CO2 emissions, accessibility inequality, and declining public transportation. Efficient vehicle dispatch algorithms that achieve both low computational cost and adequate demand assignment are needed for efficient ride-sharing services. In this research, the authors proposed and evaluated the filtering and rebalancing functions of the control center for a ride-sharing service. The filtering function to extract vehicles near the boarding point of a new demand was shown to be effective for short distance transport through the simulation case studies. Meanwhile, the effectiveness of the rebalancing function was limited and more efficient algorithms were suggested be required.

  • Parameter Identification with Machine-Learning for Traffic Model

    by Rina Okuyama, Naoto Mitsume, Hideaki Uchida, Hideki Fujii, Tomonori Yamada, Shinobu Yoshimura

    Traffic flow simulation is used for prior evaluations to solve traffic jam problems. In this paper, we propose a fast and precise traffic flow simulation method to examine various measures repeatedly. By using the Payne-Whitham model, the traffic flow simulation model based on continuum approximation, it is solved at high speed even in a section with a large amount of traffic flow. A model based on continuum approximation makes it possible to simulate traffic flow over a wide area network, but it is generally considered to be less precise because it cannot express individual vehicle characteristics and interactions. We construct a macroscopic traffic flow model so as to reproduce a microscopic traffic flow model such as multi-agent traffic flow model. The multi-agent model has already been verified to be consistent with actual traffic flow. For this purpose, we use parameter identification through a neural network to compensate the defect and to verify actual traffic flow.